On September 9, 2022 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported that Marco Taglietti, President and Chief Executive Officer of SCYNEXIS, will present in person at the upcoming H.C. Wainwright Annual Global Investment Conference and the Ladenburg Thalmann Annual Healthcare Conference (Press release, Scynexis, SEP 9, 2022, View Source [SID1234619311]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: H.C. Wainwright 24th Annual Global Investment Conference, New York
Date: Wednesday September 14, 2022
Time: 3:30 p.m. – 4:00 p.m. EDT
Format: Company presentation and 1:1 meetings
Registration: Link

Event: Ladenburg Thalmann 2022 Annual Healthcare Conference, New York
Date: Thursday, September 29, 2022
Time: 12:00 p.m. – 12:25 p.m. EDT
Format: Company presentation and 1:1 meetings
Webcast: Link
The presentations and archived webcasts can be found on the SCYNEXIS website here for 30 days following the event.